Home › Osteosarcoma › Texas › Houston

Pag-aaral pangklinika para sa Osteosarcoma sa Houston, TX

Isang pag-aaral para sa Osteosarcoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Nagre-recruitPhase 1/2

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston

12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Nagre-recruitPhase 3

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
UT MD Anderson Cancer Center, Houston

Hanggang edad 50 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05235165

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

Nagre-recruitPhase 1

Texas Children's Hospital, Houston

Edad 1 hanggang 24 · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT07211737

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Nagre-recruitPhase 1

The University of Texas MD Anderson Cancer Center, Houston

Edad 12 hanggang 50 · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT03093909

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston

Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 12 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT05019703

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

Nagre-recruitPhase 1

Texas Children's Hospital, Houston

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT04995003

Pag-aaral para sa Osteosarcoma sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.